Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reduced antibody responses against Plasmodium falciparum vaccine candidate antigens in the presence of Trichuris trichiura.
Esen M, Mordmüller B, de Salazar PM, Adegnika AA, Agnandji ST, Schaumburg F, Hounkpatin AB, Brückner S, Theisen M, Bélard S, Ngoa UA, Issifou S, Yazdanbakhsh M, Kremsner PG. Esen M, et al. Among authors: issifou s. Vaccine. 2012 Dec 14;30(52):7621-4. doi: 10.1016/j.vaccine.2012.10.026. Epub 2012 Oct 18. Vaccine. 2012. PMID: 23085365 Clinical Trial.
Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambaréné, Gabon.
Mordmüller B, Szywon K, Greutelaers B, Esen M, Mewono L, Treut C, Mürbeth RE, Chilengi R, Noor R, Kilama WL, Imoukhuede EB, Imbault N, Leroy O, Theisen M, Jepsen S, Milligan P, Fendel R, Kremsner PG, Issifou S. Mordmüller B, et al. Among authors: issifou s. Vaccine. 2010 Sep 24;28(41):6698-703. doi: 10.1016/j.vaccine.2010.07.085. Epub 2010 Aug 7. Vaccine. 2010. PMID: 20696154 Free PMC article. Clinical Trial.
A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children.
Sirima SB, Mordmüller B, Milligan P, Ngoa UA, Kironde F, Atuguba F, Tiono AB, Issifou S, Kaddumukasa M, Bangre O, Flach C, Christiansen M, Bang P, Chilengi R, Jepsen S, Kremsner PG, Theisen M; GMZ2 Trial Study Group. Sirima SB, et al. Among authors: issifou s. Vaccine. 2016 Aug 31;34(38):4536-4542. doi: 10.1016/j.vaccine.2016.07.041. Epub 2016 Jul 28. Vaccine. 2016. PMID: 27477844 Clinical Trial.
Clinical development of a VAR2CSA-based placental malaria vaccine PAMVAC: Quantifying vaccine antigen-specific memory B & T cell activity in Beninese primigravidae.
Gbédandé K, Fievet N, Viwami F, Ezinmegnon S, Issifou S, Chippaux JP, Dossou Y, Moutairou K, Massougbodji A, Ndam N, de Jongh WA, Søgaard TMM, Salanti A, Nielsen MA, Esen M, Mordmüller B, Deloron P, Luty AJF; Multi-centre research paper. Gbédandé K, et al. Among authors: issifou s. Vaccine. 2017 Jun 14;35(27):3474-3481. doi: 10.1016/j.vaccine.2017.05.027. Epub 2017 May 17. Vaccine. 2017. PMID: 28527688
Effect of immune regulatory pathways after immunization with GMZ2 malaria vaccine candidate in healthy lifelong malaria-exposed adults.
Nouatin O, Ateba Ngoa U, Ibáñez J, Dejon-Agobe JC, Mordmüller B, Edoa JR, Mougeni F, Brückner S, Bouyoukou Hounkpatin A, Esen M, Theisen M, Moutairou K, Hoffman SL, Issifou S, Luty AJF, Loembe MM, Agnandji ST, Lell B, Kremsner PG, Adegnika AA. Nouatin O, et al. Among authors: issifou s. Vaccine. 2020 Jun 2;38(27):4263-4272. doi: 10.1016/j.vaccine.2020.04.046. Epub 2020 May 5. Vaccine. 2020. PMID: 32386747 Free PMC article. Clinical Trial.
Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria.
Oyakhirome S, Issifou S, Pongratz P, Barondi F, Ramharter M, Kun JF, Missinou MA, Lell B, Kremsner PG. Oyakhirome S, et al. Among authors: issifou s. Antimicrob Agents Chemother. 2007 May;51(5):1869-71. doi: 10.1128/AAC.01448-06. Epub 2007 Feb 26. Antimicrob Agents Chemother. 2007. PMID: 17325227 Free PMC article. Clinical Trial.
111 results